Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Sanofi vet Frank Nestle joins Deerfield as partner, CEO of 3DC

Plus: Lilly CFO Anat Ashkenazi leaving for Alphabet, and updates from Y-mAbs, Danaher and more 

June 5, 2024 11:17 PM UTC

Deerfield Management named Frank Nestle partner and CEO of Deerfield Discovery and Development (3DC), succeeding Michael Foley, who will become CEO of Excelsior Sciences, a Deerfield portfolio company. Nestle was most recently global head of research and CSO at Sanofi (Euronext:SAN; NASDAQ:SNY). 

EVP and CFO Anat Ashkenazi is leaving  Eli Lilly and Co. (NYSE:LLY) to become CFO and SVP of Google and Alphabet Inc. (NASDAQ:GOOG), effective July 31. Ashkenazi held roles for 23 years at the company, becoming CFO in 2021. A search for her successor is ongoing. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article